Jean-Philippe A.
- Country
- France
- Department
- Dermatology and venereology
Research Overview
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- A MULTICOHORT, OPEN LABEL, PHASE 2 STUDY OF BOTENSILIMAB (AGEN1181) FOR TREATMENT OF ADVANCED MELANOMA REFRACTORY TO PRIOR CHECKPOINT INHIBITOR THERAPY
- Adjuvant Therapy with Pembrolizumab versus Placebo in Resected Highrisk Stage II Melanoma: A Randomized, Double-blind Phase 3 Study (KEYNOTE 716)
Data & Insights
Has run more than one trial at 104 of 212 partner sites.
Specializations
Advanced Melanoma Treatment
The investigator specializes in treating metastatic and unresectable melanoma, with particular focus on developing therapeutic approaches using novel immunotherapy combinations.
- Combined immunotherapy strategies
- BRAF V600 mutation-positive melanoma management
- Advanced-stage melanoma interventions
Expertise includes evaluating innovative treatment combinations for patients with previously untreated advanced melanoma.
Adjuvant Therapy Research
Focuses on post-surgical adjuvant treatments for different stages of melanoma, particularly investigating immunotherapy approaches in high-risk patients.
- Stage II melanoma management
- Stage III melanoma treatment
- Recurrence prevention strategies
Studies the effectiveness of various therapeutic agents in preventing melanoma recurrence after surgical resection.
Refractory Disease Management
Investigates treatment options for checkpoint inhibitor-resistant melanoma, exploring novel therapeutic approaches for patients with treatment-resistant disease.
- Alternative treatment pathways
- Combination therapy approaches
- Advanced melanoma interventions
Evaluates innovative therapeutic strategies for patients who have not responded to conventional treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.